Navigation Links
Lentigen Appoints Jim Meade as Vice President of Corporate Development
Date:6/16/2008

BALTIMORE, June 16 /PRNewswire/ -- Lentigen Corporation today announced the appointment of Jim Meade, Ph.D., CLP, as vice president of corporate development. In addition to contributing to the strategic direction of the company, Dr. Meade will be responsible for managing the development of Lentigen's partnerships, stakeholder relations, product and intellectual property portfolios, contract negotiations, and other key aspects of corporate development.

Tim Ravenscroft, CEO of Lentigen, commented, "Jim's extensive background in strategic development, opportunity evaluation, and negotiation will be an important asset to Lentigen as we continue to advance our business opportunities and collaborative relationships in biotherapeutics, vaccines and protein production."

Dr. Meade previously worked at Avalon Pharmaceuticals, where he served as vice president of business development. With more than 30 years' experience in the pharmaceutical and biotechnology industries, he has also held senior-level positions at Pharmacia, Bayer and Chiron. He holds a Ph.D. in molecular biology from the University of Texas, and is a Certified Licensing Professional and an active member of the Licensing Executives Society.

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine, and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of bench to clinical applications. Partnerships include The National Institutes of Health, The University of Pennsylvania, ThermoFisher Scientific and The U.S. Army. For further information, visit http://www.lentig
'/>"/>

SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
2. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
3. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
4. Lentigen to Move Headquarters and Manufacturing to Gaithersburg
5. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
6. VIRxSYS and Lentigen Announce Litigation Settlement
7. NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
8. Applied Computational Technologies Appoints a New CEO
9. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., , SAN FRANCISCO, Dec. 3 /PRNewswire-Fi...AP ), a biotechnology company focused on the devel...cular and metabolic disease, today announced that ...se 2 FDG-PET clinical trial of VIA-2291. ,, Th...ed out at five sites in the US and Canada includin...
(Date:12/3/2009)..., , WALTHAM, Mass., Dec. 3 /PRNewswire-F...NYSE: IMA ), a global leader in enabling individ...h the merger of rapid diagnostics and health manag...on its Series B Convertible Perpetual Preferred St... of Series B stock in an amount per share equal to...
(Date:12/2/2009)..., , COLUMBIA, Md., Dec. 2 /PRNewswire-F...q: MATK ) announced today that it intends to rele...ear 2009 on December 16, 2009, at approximately 4:... at 4:45 p.m. ET Martek will conduct a conference ... interested parties may listen to the call live vi...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ ...search report is available in its catalogue: ,,...ective ,, http://www.reportlinker.com/p016436...ective.html ,, Incubators are the most critic...r, research, and other applications for providing ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...poration (NYSE: BSX ) is scheduled to participate...ich is being held March 18 - 20 in Miami,Florida.,...ake a 25-minute,presentation on Tuesday, March 18,...o, Executive Vice President and Chief Financial Of...nswer session., A live webcast of Mr. LaViolette,...
...sory Board Programs Exemplify, Why Halogen Is th...ket, OTTAWA, March 11 /PRNewswire/ - Halogen Soft...e performance and talent management software,annou...valuable insight,into real-life HR issues and chal...the Halogen Employee Performance and Talent Manage...
...GreenField Ethanol,Canada,s largest ethanol produc...sis technology company, have signed a Binding Term...ethanol on a commercial scale., "We are excited t...ommercial reality in Canada," said Bob Gallant, Pr...onsumers are looking for a greener,affordable alte...
Other Biology Technology:Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution 2Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution 3GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality 2GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality 3
(Date:12/3/2009)... plant and animal species can be likened to emptyi...t full of potential medicines into the trash, or r...rs. , But the decline of species and their habit...ch now suggests it may also put you at greater ris...struction and biodiversity loss,"driven by the rep...
(Date:12/3/2009)...h. (Dec. 3, 2009) Van Andel Research Institute ...he plant hormone abscisic acid (ABA) works at the ...ental stresses such as drought and cold. Their fi...elp engineer crops that thrive in harsh environmen...es. The findings could also have implications for...
(Date:12/3/2009)...world when it comes to investment in energy effici...sical Sciences Research Council (EPSRC) Chief Exec...ientific and engineering research has already brou...lutions, but more investment is needed to develop ...to meet our carbon emission targets by 2020 and li...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Research is vital to a cleaner, greener, low carbon future 2Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 1Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 2Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 3Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 4Bioelements Selects Room 214 as Their Social Media and Online Marketing Agency 55283 1Bioelements Selects Room 214 as Their Social Media and Online Marketing Agency 55283 2Real Housewives of Orange County Star Gretchen Rossi Reveals Next and Best in Beauty Live from the Worlds Most Exclusive Aesthetics Conference 55278 1Real Housewives of Orange County Star Gretchen Rossi Reveals Next and Best in Beauty Live from the Worlds Most Exclusive Aesthetics Conference 55278 2Real Housewives of Orange County Star Gretchen Rossi Reveals Next and Best in Beauty Live from the Worlds Most Exclusive Aesthetics Conference 55278 3
...nish . , The daily consumption of cannabis pred...hrenia, and those episodes of psychosis which are ...haracteristics, both before their appearance and i... is one of the conclusions of the doctoral thesis ...ial psychosis: transversal analysis of the ESPIGAS...
...ile throughout life, but research at the Sahlgrens...now shown that a fertilising sperm can get help fr...nt step towards future stem cell therapy. , The r...highly correlated to the age of the mother, but is...possible explanation is that egg cells have a uniq...
...U.S., Europe, Taiwan and Japan and led by Universi...i-cancer agent that is about 200 times more active... recent clinical trials. , The study appears thi...ciety . , The new agent belongs to a class of dru...iginally developed to treat osteoporosis and other...
Other Biology News:Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia 2New drug agent knocks out multiple enzymes in cancer pathway 2
PI/RNase Staining Buffer Solution from BD Biosciences Pharmingen
Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2 from ABR-Affinity BioReagents
Mouse Anti-BCAR1 Monoclonal Antibody, Unconjugated, Clone SPM302 from Abcam
...edominantly used for labeling proteins, the single...eptides and nucleotides because they give better r...red in the conjugation processes. 5-TAMRA is more ...proteins. 6-TAMRA is predominately used for labeli...
Biology Products: